___

• 1. Powell AC, Fuchs T, Finkelstein DM, et al. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-ofhospital cardiac arrest. Circulation 1993; 88:1083- 92.
• 2. Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225–37.
• 3. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibril- lator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877–83.
• 4. Gold MR, Nisam S; Multicenter Automatic Defibrillator Implan- tation Trial, Multicenter Unsustained Tachycardia Trial. Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: Lessons learned from MADIT and MUSTT. Pacing Clin Electrophysiol 2000; 23(11 Pt 2):1981-5.
• 5. Vlay SC, Olson LC, Fricchione GL, Friedman R. Anxiety and anger in patients with ventricular tachyarrhythmias. Responses after automatic internal cardioverter defibrillator implantation. Pacing Clin Electrophysiol 1989; 12:366-73.
• 6. Bainger EM, Fernsler JI. Perceived quality of life before and after implantation of an internal cardioverter defibrillator. Am J Crit Care 1995; 4:36–43.
• 7. Schron EB, Exner DV, Yao Q, et al.; and the AVID Investigators. Quality of life in the antiarrhythmics versus implantable defibril- lator trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105:589–94.
• 8. Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol. 2006 Jun;29(6):619-26.
• 9. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-17.
• 10. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357- 65.
• 11. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT).
• 12. Bozyel S, AA Ayşen. The effect of shock therapies on health-related quality of life in patients with implantable cardioverter-defibrillator. Kocaeli Med J 2018; 7; 1:53-8.